Cargando…

The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany

SIMPLE SUMMARY: The impact of the patient’s age on head and neck cancer (HNC) treatment decision has rarely been studied worldwide. Older age cohorts account for a high proportion of HNC patients and might influence the inpatient treatment decision (surgery, radiotherapy, chemotherapy/biologicals)....

Descripción completa

Detalles Bibliográficos
Autores principales: Kouka, Mussab, Hermanns, Isabel, Schlattmann, Peter, Guntinas-Lichius, Orlando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046600/
https://www.ncbi.nlm.nih.gov/pubmed/36980666
http://dx.doi.org/10.3390/cancers15061780
_version_ 1785013714131353600
author Kouka, Mussab
Hermanns, Isabel
Schlattmann, Peter
Guntinas-Lichius, Orlando
author_facet Kouka, Mussab
Hermanns, Isabel
Schlattmann, Peter
Guntinas-Lichius, Orlando
author_sort Kouka, Mussab
collection PubMed
description SIMPLE SUMMARY: The impact of the patient’s age on head and neck cancer (HNC) treatment decision has rarely been studied worldwide. Older age cohorts account for a high proportion of HNC patients and might influence the inpatient treatment decision (surgery, radiotherapy, chemotherapy/biologicals). This population-based study in Germany between 2005 and 2018 included data of 1,226,357 HNC cases. Negative binomial regression was performed to study the time-trend analysis on treatment decision. Older age cohorts (≥65 to <80 years and ≥80 years) predominantly have led to an increase in the treatment rates (biopsy, surgery, radiotherapy, chemotherapy/biologicals), younger ones (≥35 to <50 years and ≥50 to <65 years) to a decrease. ABSTRACT: Investigations on the association between patient’s age and head and neck cancer (HNC) treatment decision are sparse. Nationwide diagnoses-related group-based data of 1,226,357 cases hospitalized with primary HNC in Germany from 2005 to 2018 were included. Negative binomial regression was performed to study the development of the treatment rates over time. For all treatment options, i.e., biopsies, surgery, radiotherapy, and chemotherapy/biologicals, increases in the treatment rates were seen in patients >80 years (surgery: oral cavity: relative risk [RR]: 1.2, CI: 1.13–1.20; oropharynx: RR: 1.2, CI: 1.15–1.34; hypopharynx: RR: 1.1, CI: 1.02–1.17; larynx: RR: 1.1, CI: 1.04–1.12; radiotherapy: oral cavity: RR: 1.1, CI: 1.07–1.23; oropharynx: RR: 1.3, CI: 1.16–1.49; hypopharynx: RR: 1.3, CI: 1.21–1.46; larynx: RR 1.2, CI: 1.03–1.29; chemotherapy: oral cavity: RR: 1.2, CI: 1.06–1.31; salivary glands: RR: 1.3, CI: 1.09–1.50; oropharynx: RR: 1.4, CI: 1.12–1.83; hypopharynx: RR: 1.3, CI: 1.06–1.48; larynx: RR: 1.3, CI: 1.08–1.52, all p < 0.05). Older age cohorts (≥80 years) need more awareness as they are mainly responsible for the increase in the rates of surgery, radiotherapy, and chemotherapy/biologics in HNC patients.
format Online
Article
Text
id pubmed-10046600
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100466002023-03-29 The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany Kouka, Mussab Hermanns, Isabel Schlattmann, Peter Guntinas-Lichius, Orlando Cancers (Basel) Article SIMPLE SUMMARY: The impact of the patient’s age on head and neck cancer (HNC) treatment decision has rarely been studied worldwide. Older age cohorts account for a high proportion of HNC patients and might influence the inpatient treatment decision (surgery, radiotherapy, chemotherapy/biologicals). This population-based study in Germany between 2005 and 2018 included data of 1,226,357 HNC cases. Negative binomial regression was performed to study the time-trend analysis on treatment decision. Older age cohorts (≥65 to <80 years and ≥80 years) predominantly have led to an increase in the treatment rates (biopsy, surgery, radiotherapy, chemotherapy/biologicals), younger ones (≥35 to <50 years and ≥50 to <65 years) to a decrease. ABSTRACT: Investigations on the association between patient’s age and head and neck cancer (HNC) treatment decision are sparse. Nationwide diagnoses-related group-based data of 1,226,357 cases hospitalized with primary HNC in Germany from 2005 to 2018 were included. Negative binomial regression was performed to study the development of the treatment rates over time. For all treatment options, i.e., biopsies, surgery, radiotherapy, and chemotherapy/biologicals, increases in the treatment rates were seen in patients >80 years (surgery: oral cavity: relative risk [RR]: 1.2, CI: 1.13–1.20; oropharynx: RR: 1.2, CI: 1.15–1.34; hypopharynx: RR: 1.1, CI: 1.02–1.17; larynx: RR: 1.1, CI: 1.04–1.12; radiotherapy: oral cavity: RR: 1.1, CI: 1.07–1.23; oropharynx: RR: 1.3, CI: 1.16–1.49; hypopharynx: RR: 1.3, CI: 1.21–1.46; larynx: RR 1.2, CI: 1.03–1.29; chemotherapy: oral cavity: RR: 1.2, CI: 1.06–1.31; salivary glands: RR: 1.3, CI: 1.09–1.50; oropharynx: RR: 1.4, CI: 1.12–1.83; hypopharynx: RR: 1.3, CI: 1.06–1.48; larynx: RR: 1.3, CI: 1.08–1.52, all p < 0.05). Older age cohorts (≥80 years) need more awareness as they are mainly responsible for the increase in the rates of surgery, radiotherapy, and chemotherapy/biologics in HNC patients. MDPI 2023-03-15 /pmc/articles/PMC10046600/ /pubmed/36980666 http://dx.doi.org/10.3390/cancers15061780 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kouka, Mussab
Hermanns, Isabel
Schlattmann, Peter
Guntinas-Lichius, Orlando
The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany
title The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany
title_full The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany
title_fullStr The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany
title_full_unstemmed The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany
title_short The Association between Patient’s Age and Head and Neck Cancer Treatment Decision—A Population-Based Diagnoses-Related Group-Based Nationwide Study in Germany
title_sort association between patient’s age and head and neck cancer treatment decision—a population-based diagnoses-related group-based nationwide study in germany
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046600/
https://www.ncbi.nlm.nih.gov/pubmed/36980666
http://dx.doi.org/10.3390/cancers15061780
work_keys_str_mv AT koukamussab theassociationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT hermannsisabel theassociationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT schlattmannpeter theassociationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT guntinaslichiusorlando theassociationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT koukamussab associationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT hermannsisabel associationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT schlattmannpeter associationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany
AT guntinaslichiusorlando associationbetweenpatientsageandheadandneckcancertreatmentdecisionapopulationbaseddiagnosesrelatedgroupbasednationwidestudyingermany